12:00 AM
 | 
Apr 24, 2000
 |  BC Week In Review  |  Company News  |  Deals

Orion Pharma, Population Council deal

The council will grant Orion exclusive worldwide rights to develop, commercialize and sublicense Nestorone synthetic progestin in transdermal dosage...

Read the full 73 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >